Yi Lu is listed as an executive officer, director, and promoter on 8 SEC Form D filings by 2 issuers between Jan 2012 and Jul 2016: ANDalyze, Inc. (Champaign, IL — other technology — 2012–2016; $2.15M reported sold to 11 investors) and GlucoSentient, Inc. (Champaign, IL — other health care — 2012; $60K reported sold to 2 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 4 years. Across those companies the filings report $2.21M sold in total.
Listed alongside Ralph Dumke (7 shared filings), Ron van Os (6 shared filings), John Regan (5 shared filings), William Thalheimer (5 shared filings), Kevin Brophy (4 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Yi. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Yi Lu and found 9 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.